Regenerative therapies are studied for a range of musculoskeletal and chronic pain conditions. Below is an overview — your candidacy can only be determined by a licensed provider.
Regenerative medicine — including mesenchymal stem cell (MSC) and platelet-rich plasma (PRP) therapies — is studied across a range of musculoskeletal and chronic pain conditions. The depth of evidence differs a lot by condition: it is strongest for the knee and thinner elsewhere. Below is a plain-language overview of where these approaches are most commonly explored, followed by a closer look at what the research actually supports for each. Throughout, remember that many of these uses are investigational and not FDA-approved, and only a licensed provider can determine whether any treatment is appropriate for you.
One of the most studied applications. May be considered for cartilage wear, meniscus issues, and osteoarthritis as an alternative to knee replacement.
Explored for degenerative disc disease, facet joint pain, and chronic lower-back conditions where surgery is being considered.
Studied for rotator cuff injuries, labral tears, and shoulder osteoarthritis that limit range of motion and daily activity.
May be considered for hip osteoarthritis, bursitis, and labral pathology as a non-surgical option to evaluate.
Regenerative approaches aim to address inflammation and cartilage degeneration associated with osteoarthritis in multiple joints.
Investigated for certain types of peripheral neuropathy and nerve-related pain. Candidacy varies widely and requires evaluation.
For age- or activity-related cartilage and connective-tissue degeneration affecting mobility and comfort.
Tendon, ligament, and soft-tissue injuries that limit movement and have not responded to conservative care.
Platelet-rich plasma injections studied for knee, shoulder, hip, and soft-tissue pain — often compared with stem cell therapy.
The knee is the most studied joint in regenerative medicine. A 2020 meta-analysis of nine randomized controlled trials of stem cell therapy for knee osteoarthritis reported improvements in some pain and function scores — an encouraging signal — though the authors cautioned that the trials were small and varied, and that larger, longer studies are still needed. It is reasonable to consider regenerative options before irreversible surgery, with a physician's input. Read more: Stem cell therapy for knee pain.
Research into MSCs for degenerative disc disease and chronic low-back pain is growing but earlier-stage, based largely on smaller studies. Early results for discogenic pain are promising but not conclusive. Related reading: stem cells and back injuries.
Evidence for the shoulder — rotator cuff injuries, labral issues, and osteoarthritis — is emerging, with a smaller but increasing body of research compared with the knee. Treatment is investigational and outcomes vary. Read more: stem cell therapy for shoulder pain.
The hip has fewer high-quality studies than the knee. Regenerative approaches are sometimes explored for hip osteoarthritis, bursitis, and labral pathology as a non-surgical option to evaluate with a qualified provider. Read more: stem cell therapy for hip pain.
Much of the interest in MSCs centers on their anti-inflammatory and immunomodulatory signaling rather than wholesale tissue regrowth. This helps explain why some patients report relief even when imaging shows limited structural change — and why "guaranteed cartilage regrowth" claims should be viewed skeptically. Read more: stem cell therapy for arthritis & osteoarthritis.
Certain types of peripheral neuropathy and nerve-related pain are being investigated, but candidacy varies widely and the evidence is early. A thorough physician evaluation is essential before considering any regenerative approach here. Read more: stem cell therapy for neuropathy.
Tendon, ligament, and soft-tissue injuries are often studied alongside platelet-rich plasma (PRP), with mixed and limited results to date. These are typically considered when conservative care has not helped and surgery is on the table.
For a deeper, fully sourced review, see our MSC research for orthopedic pain pillar and our complete guide to stem cell research. To understand the regulatory picture, see our guide to FDA approval and safety of stem cell therapy.
Complete a brief assessment and we'll match you with a board-certified, verified clinic in your area to discuss your specific condition.
Begin Your Assessment